Lithium and Valproic Acid in Bipolar Disorders and Beyond

Marco      Scarselli

doi:10.2174/1570159X2104230307123319

« Previous Next »

[1]
Sani, G.; Perugi, G.; Tondo, L. Treatment of bipolar disorder in a lifetime perspective: Is lithium still the best choice? Clin. Drug Investig.,  2017, 37(8), 713-727.
 [http://dx.doi.org/10.1007/s40261-017-0531-2] [PMID:  28477315]

[2]
Malhi, G.S.; Outhred, T. Therapeutic mechanisms of lithium in bipolar disorder: Recent advances and current understanding. CNS Drugs,  2016, 30(10), 931-949.
 [http://dx.doi.org/10.1007/s40263-016-0380-1] [PMID:  27638546]

[3]
Geddes, J.R.; Goodwin, G.M.; Rendell, J.; Azorin, J-M.; Cipriani, A.; Ostacher, M.J.; Morriss, R.; Alder, N.; Juszczak, E. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (balance): A randomised open-label trial. Lancet,  2010, 375(9712), 385-395.
 [http://dx.doi.org/10.1016/S0140-6736(09)61828-6] [PMID:  20092882]

[4]
Salloum, I.M.; Cornelius, J.R.; Daley, D.C.; Kirisci, L.; Himmelhoch, J.M.; Thase, M.E. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: A double-blind placebo-controlled study. Arch. Gen. Psychiatry,  2005, 62(1), 37-45.
 [http://dx.doi.org/10.1001/archpsyc.62.1.37] [PMID:  15630071]

[5]
Vieta, E.; Berk, M.; Schulze, T.G.; Carvalho, A.F.; Suppes, T.; Calabrese, J.R. Bipolar disorders; Nat Rev Dis Prim, 2018, p. 4.

[6]
Maletic, V.; Raison, C. Integrated neurobiology of bipolar disorder. Front. Psychiatry,  2014, 5, 98.
 [http://dx.doi.org/10.3389/fpsyt.2014.00098] [PMID:  25202283]

[7]
Gignac, A.; McGirr, A.; Lam, R.W.; Yatham, L.N. Recovery and recurrence following a first episode of mania: A systematic review and meta-analysis of prospectively characterized cohorts. J. Clin. Psychiatry,  2015, 76(9), 1241-1248.
 [http://dx.doi.org/10.4088/JCP.14r09245] [PMID:  25845021]

[8]
Aringhieri, S.; Carli, M.; Kolachalam, S.; Verdesca, V.; Cini, E.; Rossi, M.; McCormick, P.J.; Corsini, G.U.; Maggio, R.; Scarselli, M. Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences. Pharmacol. Ther.,  2018, 192, 20-41.
 [http://dx.doi.org/10.1016/j.pharmthera.2018.06.012] [PMID:  29953902]

[9]
Carlson, G.A.; Kotov, R.; Chang, S.W.; Ruggero, C.; Bromet, E.J. Early determinants of four-year clinical outcomes in bipolar disorder with psychosis. Bipolar Disord.,  2012, 14(1), 19-30.
 [http://dx.doi.org/10.1111/j.1399-5618.2012.00982.x] [PMID:  22329469]

[10]
Pisano, S.; Pozzi, M.; Catone, G.; Scrinzi, G.; Clementi, E.; Coppola, G.; Milone, A.; Bravaccio, C.; Santosh, P.; Masi, G. Putative mechanisms of action and clinical use of lithium in children and adolescents: A critical review. Curr. Neuropharmacol.,  2019, 17(4), 318-341.
 [http://dx.doi.org/10.2174/1570159X16666171219142120] [PMID:  29256353]

[11]
Lipska, K.; Gumieniczek, A.; Filip, A.A. Anticonvulsant valproic acid and other short-chain fatty acids as novel anticancer therapeutics: Possibilities and challenges. Acta Pharm.,  2020, 70(3), 291-301.
 [http://dx.doi.org/10.2478/acph-2020-0021] [PMID: 32074065]

[12]
Zusky, P.M.; Biederman, J.; Rosenbaum, J.F.; Manschreck, T.C. Adjunct low dose lithium carbonate in treatment-resistant depression a placebocontrolled study. J. Clin. Psychopharmacol.,  1988, 8(2), 120-124.

Rights & Permissions Print Cite

Article Metrics

46

2

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1570159X2104230307123319	Print ISSN 1570-159X
Publisher Name Bentham Science Publisher	Online ISSN 1875-6190

Current Neuropharmacology

Lithium and Valproic Acid in Bipolar Disorders and Beyond

Related Journals

Related Books